The SARS-CoV-2 is a coronavirus causing a human infection designated as COVID-19 by the World Health Organization. Up to 5% of symptomatic patients are admitted to intensive care unit (ICU) for acute respiratory distress syndrome (ARDS), sepsis and multiple organ failure. Clotting abnormalities have been documented in COVID-19 patients [1], eventually culminating in DIC in patients with poor prognosis [2]. However, the occurrence of consumption coagulopathy has been questioned by some reports [
Clotting abnormalities in critically ill COVID-19 patients are inconsistent with overt disseminated intravascular coagulation
Paparella D.;Colucci M.;Mariggio M. A.;Grasso S.
2020-01-01
Abstract
The SARS-CoV-2 is a coronavirus causing a human infection designated as COVID-19 by the World Health Organization. Up to 5% of symptomatic patients are admitted to intensive care unit (ICU) for acute respiratory distress syndrome (ARDS), sepsis and multiple organ failure. Clotting abnormalities have been documented in COVID-19 patients [1], eventually culminating in DIC in patients with poor prognosis [2]. However, the occurrence of consumption coagulopathy has been questioned by some reports [File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
PIIS0049384820305193.pdf
non disponibili
Descrizione: articolo principale
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright dell'editore
Dimensione
924.83 kB
Formato
Adobe PDF
|
924.83 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
